BPI 2026 · CDMO & CRO

Kemwell Biopharma at BPI 2026

Bengaluru, India

Kemwell Biopharma brings 1 presentation to BPI 2026 in Boston, and exhibits at Booth 515. Kemwell Biopharma is a CDMO that develops processes and makes protein therapeutics from mammalian cells for clinical and commercial use. Its session covers scaling downstream processes from the lab to GMP manufacturing.

OrganizationBPI 2026 Attendance
Kemwell Biopharma
Bengaluru, India
1 Vice President -Quality
kemwellbiopharma.com
CDMO & CROExhibitor
Biologics CDMO providing process development and clinical and commercial manufacturing of mammalian-cell-derived protein therapeutics.
Booth
Exhibiting at Booth 515
Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm
Panel
Wed Sep 23
2:00pm–2:30pm
PANEL DISCUSSION: Scaling Downstream Processes: From Lab to GMP Manufacturing
Downstream Processing · with Hinge Bio, Amgen, University College London +1 more

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Kemwell Biopharma

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction